Saturday, June 10, 2023 5:03:23 PM
Thank you, Gary, for conceding my point about the data not being peer-reviewed. And I'll concede Dr. Bala's point I may have overstated my case when I called Dr. Bosch presentation "not scientific." The topic is certainly biomedicine/immunology, which of course is scientific.
But my main beef is that it hasn't been peer reviewed, and so far as we know it hasn't even been submitted for publication in a peer-reviewed journal. There's been no vetting by an objective third party. The slide below is a good example. We're all taking this as if it's the gospel truth, but who else, besides NW Bio, has vouched for the accuracy of these data? The people who make decisions, for example formulary decisions, or treatment recommendations, and who will be held accountable for their actions by others, will wait until they see data that have been confirmed by publication in a peer-reviewed journal.
But my main beef is that it hasn't been peer reviewed, and so far as we know it hasn't even been submitted for publication in a peer-reviewed journal. There's been no vetting by an objective third party. The slide below is a good example. We're all taking this as if it's the gospel truth, but who else, besides NW Bio, has vouched for the accuracy of these data? The people who make decisions, for example formulary decisions, or treatment recommendations, and who will be held accountable for their actions by others, will wait until they see data that have been confirmed by publication in a peer-reviewed journal.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
